* Conmed Corp CNMD.N reported quarterly adjusted earnings
of 42
cents per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for earnings
of 90 cents per share.
* Revenue fell 8.4% to $250.87 million from a year ago;
analysts
expected $302.51 million.
* Conmed Corp's reported EPS for the quarter was 86 cents.
* The mean earnings estimate of analysts had fallen by
about 10.1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Conmed Corp shares had risen by 12.0% this quarter.
* The company reported quarterly net income of $26.58
million.
* Wall Street's median 12-month price target for Conmed Corp
is
$103.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
2 at 10:57 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 0.90 0.42 Missed
Sep. 30 2022 0.75 0.77 Beat
Jun. 30 2022 0.75 0.76 Beat
Mar. 31 2022 0.62 0.70 Beat